As of 2025-07-14, the Gross Margin of OncoTherapy Science Inc (4564.T) is -29.1%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-03-31 | -29.1% |
2023-03-31 | 3.7% |
2022-03-31 | 9.9% |
2021-03-31 | 5.9% |
2020-03-31 | -15.8% |
2019-03-31 | - |
2018-03-31 | - |
2017-03-31 | - |
2016-03-31 | - |
2015-03-31 | - |